<DOC>
	<DOCNO>NCT00944346</DOCNO>
	<brief_summary>- Objective : - A Randomized , Two-Way Crossover , Single-Dose , Open-Label Study Evaluate Bioequivalence Test Tablet Formulation Metformin HCl ( 1000 mg ) , Compared Equivalent Dose Commercially Available Reference Drug Product ( Glucophage® , Bristol-Myers Squibb Company ) Fasted , Healthy , Adult Subjects . - Study Design : - Randomized , single-dose,2-way crossover .</brief_summary>
	<brief_title>Study Evaluate Bioequivalence Test Tablet Formulation Metformin HCl ( 1000 mg ) , Compared Equivalent Dose Commercially Available Reference Drug Product ( Glucophage® , Bristol-Myers Squibb Company ) Fed , Healthy , Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Subject least 18 year old . Subject clinically significant abnormal lab value screen evaluation . Subject 's drug abuse , Hepatitis B , Hepatitis C , HIV screening negative nonrelative . Acceptable screen ECG . Female subject 's pregnancy test screen negative . Subject evidence underlie disease preentry physical examination . Subject give write consent participate . Female subject receive injectable implantable contraceptive period six month precede study . Agreed undergo least 14day predose washout . Beginning two week prior dose throughout study , female subject childbearing potential agrees utilize one follow method contraception : 1 . Condom topical spermicide 2 . Condom diaphragm 3 . Intrauterine device ( I.U.D ) 4 . Complete abstinence . Agree abstain consume caffeine alcohol least 48 hour . prior study throughout blood collection period . History treatment alcoholism , substance abuse , drug abuse past 24 month . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . History GRD , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease . History treatment asthma , hypoxemia , dehydration , sepsis , metabolic acidosis congestive heart failure . Subject pregnant lactating . History drug hyper sensitivity . Subject treated investigational drug four week prior initial dose study . Subject smoke 15 cigarette per day use tobacco product currently use nicotine product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>